incyte corp (INCY:NASDAQ GS)
Richard U. De Schutter
Chairman, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Finance Committee, Incyte Corporation
|Age||Total Calculated Compensation||This person is connected to 52 board members in 9 different organizations across 17 different industries.|
See Board Relationships
Mr. Richard U. De Schutter has been the President of L.B. Gemini, Inc. since 2000. Mr. De Schutter served as an Operating Partner of Linden LLC. He served as Executive Chairman, Chief Executive Officer and President of DuPont Pharmaceutical Company from 2000 to December 2001. He joined DuPont Pharmaceutical Company in 2000. From January 1999 to March 2000, he served as the Chief Administration Officer of Monsanto Company, where he served for 35 years. He served as the ...
Experimental StationPhone: 302-498-6700
Wilmington, Delaware 19880
Board Members Memberships*
Independent Director, Chairman of Nominating & Governance Committee, Member of Audit Committee and Member of Compensation Committee
Chairman, President, and Chief Executive Officer
Former Chairman and Chief Executive Officer
Former Chairman of the Board
Director and Chairman of Organization & Compensation Committee
Former Vice Chairman, Chief Administrative Officer, Chairman of G D Searle & Co, Chief Executive Officer of G D Searle & Co and President of G D Searle & Co
Former Senior Independent Non-Executive Director, Member of Audit Committee, Member of Ethics & Compliance Committee and Member of Nomination & Governance Committee
Chairman, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Finance Committee
Non-Executive Director, Member of Audit Committee and Member of Remuneration Committee
Former Independent Director, Vice Chairman of Governance Committee and Member of Audit Committee
Chairman, Chairman of Compensation Committee and Member of Governance & Nominating Committee
The University of Arizona
The University of Arizona
Columbia Business School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Harvey J. Berger M.D.||Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee|
Ariad Pharmaceuticals Inc.
|Ron Squarer BSc (Biochemistry), MBA||Chief Executive Officer and Director|
Array BioPharma, Inc.
|James A. Bianco M.D.||Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee|
CTI BioPharma Corp.
|Werner Lanthaler MBA,MPA||Chief Executive Officer|
|€601.0K||Compensation as of Fiscal Year 2013.|